ABL's clinical advisory board is composed of academic and private researchers and HIV medical doctors who are experienced HIV disease management and conversant with the bio-tech and software technologies we utilize.
The scientific advisory board counsels the ABL on our products and specific projects, new products under development, and our scheduled product updates. clinical trials and updates on new discoveries.
ABL consults with our users on a regular basis for requirements analysis and usability feedback. If you would like to join our user panel please send an email to partners@ablsa.com.
Jean Claude Schmit, M.D. :: Luxembourg
Staff member in the National Service of Infectious Diseases and Microbiology Laboratory, Centre Hospitalier de Luxembourg Scientific coordinator of the Retrovirology Laboratory, Centre de Recherche Public-Santé, Luxembourg.
Dr. Ricardo Sohbie Diaz :: Brazil
Assistant Professor, Department of Infectious Diseases Retrovirology Laboratory, Federal University of São Paulo, Director Consultant of the STD/AIDS National Committee of Brazilian Ministry of Health Paulista School of Medicine, Federal University of São Paulo.
Arsene Kronshagen :: Chairman of the Board
Mr. Kronshagen has served as the Chairman of the Board and the General Counsel of ABL since it's founding in 2000.
Jean Claude Schmit, M.D. :: Director
Dr. Schmit is a co-founder, member of the Board of Directors and serves as the Acting Chief Scientific and Medical Officer.
Chalom Sayada, M.D. Ph.D. :: Director
Dr. Sayada is a co-founder, member of the Board of Directors and Administrateur delegue.
Marc Van Rompaey :: Director
Mr. Van Rompaey is the Chairman of the Board of TherapyEdge Inc.
Philippe Deville :: representative of Sparaxis (Group SRIW), director.
Mr Deville is the representative of SRIW (Société Régionale d'Investissement de Wallonie SA, www.sriw.be).
Daniel Gheza :: Director
Mr Gheza is the representative of EUREFI (www.eurefi.org).